Comparison of Escalating Doses of IncobotulinumtoxinA (Xeomin®) in the Treatment of Glabellar Rhytids

NCT01583478 · clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
15
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The Maas Clinic

Collaborators